Ryo Nagasawa
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 5
- Chronic Kidney Disease and Diabetes 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 10
- Chronic Obstructive Pulmonary Disease (COPD) Research 7
-
- Heme Oxygenase-1 and Carbon Monoxide 4
-
- Sarcoidosis and Beryllium Toxicity Research 3
-
- Occupational exposure and asthma 3
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Hisahiro YoshidaTetsuya MitaraiHitoshi KuboYoichi MiyazakiYoshiaki KawaguchiOsamu SakaiIekuni IchikawaT Kitajima
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ryo Nagasawa
26 papers receiving 485 citations
Peers
Comparison fields: 5 of 71
- Nephrology 123
- Endocrinology, Diabetes and Metabolism 140
- Cardiology and Cardiovascular Medicine 186
- Genetics 56
- Immunology 81
Countries citing papers authored by Ryo Nagasawa
This map shows the geographic impact of Ryo Nagasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Nagasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Nagasawa more than expected).
Fields of papers citing papers by Ryo Nagasawa
This network shows the impact of papers produced by Ryo Nagasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Nagasawa. The network helps show where Ryo Nagasawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryo Nagasawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 6 | |
| 11 | [A Case of Significant Ejection Fraction Reduction and Heart Failure Induced by Osimertinib]. | 2020 | 3 |
| 12 | A case of drug-induced lung injury induced by abiraterone acetate linked to serum heme oxygenase-1 | 2020 | 1 |
| 13 | 2020 | 0 | |
| 14 | 2020 | 10 | |
| 15 | 1999 | 3 | |
| 16 | 1999 | 1 | |
| 17 | 1997 | 53 | |
| 18 | Reconstitution of SCID mouse with tonsillar cells from patients with IgA nephropathy. | 1996 | 1 |
| 19 | 1995 | 261 | |
| 20 | 1994 | 19 |
About Ryo Nagasawa
Ryo Nagasawa is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine, having authored 27 papers that have together received 515 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers), Renal Diseases and Glomerulopathies (5 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), Occupational exposure and asthma (3 papers), Chronic Kidney Disease and Diabetes (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Nephrology (123 citations), Endocrinology, Diabetes and Metabolism (140 citations) and Cardiology and Cardiovascular Medicine (186 citations). Ryo Nagasawa has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hisahiro Yoshida, Tetsuya Mitarai, Hitoshi Kubo, Yoichi Miyazaki, Yoshiaki Kawaguchi, Osamu Sakai, Iekuni Ichikawa, T Kitajima, Tetsuya Kawamura and Naoki Maruyama. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.